APO RESEARCH · REPORT
Mebendazole
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
Product & engineering
Understand the product.
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
Selected research
Industry Research
Mebendazole Industry Research Report 2026
Market perspective
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
The classification of Mebendazole includes Tablet and Oral Suspension. The proportion of Tablet in 2019 is about 86%.
Mebendazole is widely used for <2 Years Old and >=2 Years Old. The most proportion of Mebendazole used for >=2 Years Old, and the proportion in 2019 is about 74%.
Read the full market overview
Asia Pacific is the largest market, with a sales market share nearly 35% in 2019. Following Asia Pacific, North America is the second largest sales place with the sales market share of about 21%.
Report Scope
This report quantifies the global Mebendazole market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Mebendazole Market by Company
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
Mebendazole Segment by Type
Tablet
Oral Suspension
Mebendazole Segment by Application
Below 2 Years Old
Above 2 Years Old
Mebendazole Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mebendazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mebendazole and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mebendazole.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Mebendazole manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Mebendazole by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Mebendazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Oral Suspension
Applications
- Below 2 Years Old
- Above 2 Years Old
Companies covered
- Johnson & Johnson
- Amneal Pharmaceuticals
- Cadila Pharmaceuticals
- Eipico
- Esteve Pharmaceuticals
- Tenry
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Mebendazole Market Size (2021-2032)
- 2.2.2 Global Mebendazole Sales (2021-2032)
- 2.2.3 Global Mebendazole Market Average Price (2021-2032)
- 2.3 Mebendazole by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet
- 2.3.3 Oral Suspension
- 2.4 Mebendazole by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Below 2 Years Old
- 2.4.3 Above 2 Years Old
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Mebendazole Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Mebendazole Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Mebendazole Revenue of Manufacturers (2021-2026)
- 3.4 Global Mebendazole Average Price by Manufacturers (2021-2026)
- 3.5 Global Mebendazole Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Mebendazole, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Mebendazole, Product Type & Application
- 3.8 Global Manufacturers of Mebendazole, Established Date
- 3.9 Global Mebendazole Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson & Johnson
- 4.1.1 Johnson & Johnson Company Information
- 4.1.2 Johnson & Johnson Business Overview
- 4.1.3 Johnson & Johnson Mebendazole Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson & Johnson Mebendazole Product Portfolio
- 4.1.5 Johnson & Johnson Recent Developments
- 4.2 Amneal Pharmaceuticals
- 4.2.1 Amneal Pharmaceuticals Company Information
- 4.2.2 Amneal Pharmaceuticals Business Overview
- 4.2.3 Amneal Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Amneal Pharmaceuticals Mebendazole Product Portfolio
- 4.2.5 Amneal Pharmaceuticals Recent Developments
- 4.3 Cadila Pharmaceuticals
- 4.3.1 Cadila Pharmaceuticals Company Information
- 4.3.2 Cadila Pharmaceuticals Business Overview
- 4.3.3 Cadila Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cadila Pharmaceuticals Mebendazole Product Portfolio
- 4.3.5 Cadila Pharmaceuticals Recent Developments
- 4.4 Eipico
- 4.4.1 Eipico Company Information
- 4.4.2 Eipico Business Overview
- 4.4.3 Eipico Mebendazole Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Eipico Mebendazole Product Portfolio
- 4.4.5 Eipico Recent Developments
- 4.5 Esteve Pharmaceuticals
- 4.5.1 Esteve Pharmaceuticals Company Information
- 4.5.2 Esteve Pharmaceuticals Business Overview
- 4.5.3 Esteve Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Esteve Pharmaceuticals Mebendazole Product Portfolio
- 4.5.5 Esteve Pharmaceuticals Recent Developments
- 4.6 Tenry
- 4.6.1 Tenry Company Information
- 4.6.2 Tenry Business Overview
- 4.6.3 Tenry Mebendazole Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Tenry Mebendazole Product Portfolio
- 4.6.5 Tenry Recent Developments
5 Global Mebendazole Market Scenario by Region
- 5.1 Global Mebendazole Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Mebendazole Sales by Region: 2021-2032
- 5.2.1 Global Mebendazole Sales by Region: 2021-2026
- 5.2.2 Global Mebendazole Sales by Region: 2027-2032
- 5.3 Global Mebendazole Revenue by Region: 2021-2032
- 5.3.1 Global Mebendazole Revenue by Region: 2021-2026
- 5.3.2 Global Mebendazole Revenue by Region: 2027-2032
- 5.4 North America Mebendazole Market Facts & Figures by Country
- 5.4.1 North America Mebendazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Mebendazole Sales by Country (2021-2032)
- 5.4.3 North America Mebendazole Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Mebendazole Market Facts & Figures by Country
- 5.5.1 Europe Mebendazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Mebendazole Sales by Country (2021-2032)
- 5.5.3 Europe Mebendazole Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Mebendazole Market Facts & Figures by Country
- 5.6.1 Asia Pacific Mebendazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Mebendazole Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Mebendazole Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Mebendazole Market Facts & Figures by Country
- 5.7.1 South America Mebendazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Mebendazole Sales by Country (2021-2032)
- 5.7.3 South America Mebendazole Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Mebendazole Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Mebendazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Mebendazole Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Mebendazole Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Mebendazole Sales by Type (2021-2032)
- 6.1.1 Global Mebendazole Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Mebendazole Sales Market Share by Type (2021-2032)
- 6.2 Global Mebendazole Revenue by Type (2021-2032)
- 6.2.1 Global Mebendazole Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Mebendazole Revenue Market Share by Type (2021-2032)
- 6.3 Global Mebendazole Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Mebendazole Sales by Application (2021-2032)
- 7.1.1 Global Mebendazole Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Mebendazole Sales Market Share by Application (2021-2032)
- 7.2 Global Mebendazole Revenue by Application (2021-2032)
- 7.2.1 Global Mebendazole Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Mebendazole Revenue Market Share by Application (2021-2032)
- 7.3 Global Mebendazole Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Mebendazole Value Chain Analysis
- 8.1.1 Mebendazole Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Mebendazole Production Mode & Process
- 8.2 Mebendazole Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Mebendazole Distributors
- 8.2.3 Mebendazole Customers
9 Global Mebendazole Analyzing Market Dynamics
- 9.1 Mebendazole Industry Trends
- 9.2 Mebendazole Industry Drivers
- 9.3 Mebendazole Industry Opportunities and Challenges
- 9.4 Mebendazole Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst